Use of Regranex gel for diabetic foot ulcers.
Piascik
P
P
University of Kentucky College of Pharmacy, Lexington, USA.
D000925:Anticoagulants / Q000627:therapeutic use*; D000077214:Becaplermin; D002986:Clinical Trials as Topic; D017719:Diabetic Foot / Q000188:drug therapy* / Q000503:physiopathology; D005782:Gels; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D014481:United States; D014945:Wound Healing / Q000502:physiology
D000925:Anticoagulants; D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin